REFERENCES
- Kan YW. Molecular pathology of α-thalassemia. Ann NY Acad Sci. 1985; 445: 28–36
- Higgs DR, Vickers MA, Wilkie AOM, Pretorius I-M, Jarman AP, Weatherall DJ. A review of the molecular genetics of the human α-globin gene cluster. Blood. 1989; 73(5)1081–1084
- Neishabury M, Oberkanins C, Moheb LA, et al. High prevalence of the −α3.7 deletion among thalassemia patients in Iran. Hemoglobin 2003; 27(1)53–55
- Garshasbi M, Oberkanins C, Law HY, Neishabury M, Kariminejad R, Najmabadi H. α-Globin gene deletion and point mutation analysis among Iranian patients with microcytic hypochromic anemia. Haematologica. 2003; 88(10)1196–1197
- Mosca A, Paleari R, Ivaldi G, Galanallo R, Giordano PC. The role of Hemoglobin A2 testing in the diagnosis of thalassemias and related hemoglobinopathies. J Clin Pathol. 2009; 62(1)13–17
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 1988; 16(3)1215
- Baysal E, Huisman THJ. Detection of common deletional α-thalassemia-2 determinants by PCR. Am J Hematol. 1994; 46(3)208–213
- Nozari G, Rahbar S, Golshalyzan A, Rahmanzadeh S. Molecular analyses of β-thalassemia in Iran. Hemoglobin. 1995; 19(6)425–431
- Yavarian M, Harteveld CL, Batelaan D, Bernini LF, Giordano PC. Molecular spectrum of β-thalassemia in the Iranian province of Hormozgan. Hemoglobin. 2001; 25(1)35–43
- Najmabadi H, Karimi-Nejad R, Sahebjam S, et al. The β‐thalassemia mutation spectrum in the Iranian population. Hemoglobin. 2001; 25(3)285–296
- Najmabadi H, Pourfathollah AA, Neishabury M, Sahebjam F, Krugluger W, Oberkanins C. Rare and unexpected mutations among Iranian β-thalassemia patients and prenatal samples discovered by reverse-hybridization and DNA sequencing. Haematologica 2002; 87(10)1113–1114
- Gohari LH, Petrou M, Felekis X, Christopoulos G, Kleanthous M. Identification of α-thalassemia mutations in Iranian individuals with abnormal hematological indices and normal Hb A2. Hemoglobin. 2003; 27(2)129–132
- Harteveld CL, Yavarian M, Zorai A, Quakkelaar ED, van Delft P, Giordano PC. Molecular spectrum of α-thalassemia in the Iranian population of Hormozgan: Three novel point mutation defects. Am J Hematol. 2003; 74(2)99–103
- Yavarian M, Karimi M, Zorai A, Harteveld CL, Giordano PC. Molecular basis of Hb H disease in southwest Iran. Hemoglobin. 2005; 29(1)43–50
- El-Kalla S, Baysal E. Thalassemia in United Arab Emirates. Acta Haematol. 1998; 100(1)49–53
- Zandian K, Nateghi J, Keikhaie B, et al. α-Thalassemia mutations in Khuzestan Province, Southwest Iran. Hemoglobin. 2008; 32(6)546–552
- Harteveld CL, Traeger-Synodinos J, Ragusa A, et al. Different geographic origins of Hb Constant Spring [α2 codon142 TAA>CAA]. Haematologica 2001; 86(1)36–38
- Kanavakis E, Papassotiriou I, Karagiorga M, et al. Phenotypic and molecular diversity of Haemoglobin H disease: A Greek experience. Br J Haematol. 2000; 111(3)915–923
- Harteveld CL, Voskamp A, Phylipsen M, et al. Nine unknown rearrangements in 16p13.3 and 11p15.4 causing α- and β-thalassemia characterized by high resolution multiplex ligation-dependent probe amplification. J Med Genet. 2005; 42(12)922–931
- Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ 2004; 329(7475)1134–1137
- Najmabadi H, Ghamari A, Sahebjam F, et al. Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet. 2006; 9(2)93–97